Pulsatilla (pratensis)
Generic Name: pulsatilla (pratensis)
Brand Names:
Pulsatilla
INDICATIONS: May temporarily relieve menstrual pain, irregularity, and moodiness, especially with shifting, changeable symptoms.
Overview
INDICATIONS: May temporarily relieve menstrual pain, irregularity, and moodiness, especially with shifting, changeable symptoms.
Uses
INDICATIONS: May temporarily relieve menstrual pain, irregularity, and moodiness, especially with shifting, changeable symptoms.
Dosage
DIRECTIONS: Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS: If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
Frequently Asked Questions
What is Pulsatilla (pratensis) used for?▼
INDICATIONS: May temporarily relieve menstrual pain, irregularity, and moodiness, especially with shifting, changeable symptoms.
What are the important warnings for Pulsatilla (pratensis)?▼
WARNINGS: If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
Related Medications
Eczema Wipes
eczema wipes
Non-Standardized Food Allergenic Extract [EPC]
Purpose Antiseptic, Antifungal Wet Wipes
Petroleum
petroleum
Purpose Skin protectant
Brinzolamide/brimonidine Tartrate
brinzolamide/brimonidine tartrate
Carbonic Anhydrase Inhibitor [EPC]
11 DESCRIPTION SIMBRINZA (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% is a fixed combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergic receptor agonist for topical ophthalmic use. Brinzolamide is described chemically as: (R)-(+)-4-Ethylamino-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno [3,2-e]-1,2-thiazine-6-sulfonamide-1,1- dioxide.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.